The GLP1R rs6923761 variant and MC4R rs17782313 polymorphisms influence GI sensitivity to GLP-1 medications
Midpoint Evaluation At six months, researchers may compare changes in body weight, waist circumference, metabolic health, appetite, and side effects with earlier measurements
Overall, the regulatory landscape for GLP-1 friendly claims on food products is still shifting
A class action lawsuit involves a group of plaintiffs who have suffered similar harm from the same defendant, and their cases are combined into a single lawsuit
At the opening of the 2023 annual meeting of the American Heart Association in Philadelphia, results of a clinical trial generated tremendous interest: Semaglutide, it appeared, was a new tool to treat heart disease